Table 108Cost minimisation analysis of PCA compared with intermittent administration of morphine: parameters (adults)

ParameterIntermittentPCASource
N1Mean2Min3Max4N1Mean2Min3Max4
No. of doses/changes per day161121112GDG
Administration time
 initial set-up (mins)110520231.251555GDG
 time per subsequent dose/change (mins)110520216.25525GDG
 nurses per set-up/dose/change12222222GDG
Observations
 no. of obs. required/day110520215624GDG
 nurses per obs.11112111GDG
 length of time per obs. (mins)1521025.271210GDG
Resource use
 syringes (per day)1122242102GDG
 PCA admin. sets (per day)100020.330.330.33GDG
 average LOS (days)mean=3.7; median=2HES 2010/11
Costs
 cost of PCA admin. set9.25NHS supply chain catalogue 2011
 cost of PCA pump (£)2495Manufacturer
 5ml syringe hypodermic (£)0.11NHS supply chain catalogue 2011
 nursing time per hr (£)52PSSRU 2011
1

number of GDG members providing estimates;

2

mean of values provided by GDG members;

3

minimum possible value provided by the GDG;

4

maximum possible value provided by the GDG

number of GDG members providing estimates;

mean of values provided by GDG members;

minimum possible value provided by the GDG;

maximum possible value provided by the GDG

From: Appendix F, Full health economic report

Cover of Sickle Cell Acute Painful Episode
Sickle Cell Acute Painful Episode: Management of an Acute Painful Sickle Cell Episode in Hospital.
NICE Clinical Guidelines, No. 143.
Centre for Clinical Practice at NICE (UK).
Copyright © 2012, National Institute for Health and Clinical Excellence.

All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.